Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01675479 · ClinicalTrials.gov registry record · NA
Safety and Effectiveness of Wavefront-Guided LASIK Correction of Hyperopic Refractive Errors
A NA study of Hyperopia, sponsored by Abbott Medical Optics.
- Completed
- Registry status
- NA
- Development phase
- 167
- Enrollment target
- 9
- Study locations
NCT01675479 is a NA study of Hyperopia that has completed, run by Abbott Medical Optics. The registered enrollment target is 167 participants, above the 108-participant average among 10 other Hyperopia trials with a reported enrollment target (55% higher). The trial reports 9 study locations across 8 states.
The verdict
NCT01675479, a NA study of Hyperopia, has completed, sponsored by Abbott Medical Optics.
- COMPLETED
- Registry status
- NA
- Development phase
- 167 participants
- Enrollment target
- 9
- Study locations
Study Summary
Demonstrate that wavefront-guided LASIK using measurements from the iDesign System is safe and effective for the treatment of Hyperopia.
Conditions Studied
Interventions
- DEVICE LASIK correction of hyperopic refractive errors
Study Locations (9)
Missouri
- Pepose Vision Institute - Chesterfield
- Durrie Vision - Kansas City
California
- Maloney Vision Institute - Los Angeles
Florida
- University of Miami Bascom Palmer Eye Institute - Miami
Illinois
- Kraff Eye Institute - Chicago
New Mexico
- Coleman Vision - Albuquerque
Texas
- Lehmann Eye Center - Nacogdoches
Virginia
- The Eye Center - Fairfax
Washington
- King LASIK - Renton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 167 participants |
| Start Date | 2012-12-31 |
| Est. Completion | 2016-10-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01675479
The ClinicalTrials.gov registry entry for NCT01675479 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 167 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 108-participant average among 10 other Hyperopia trials with a reported enrollment target (55% higher). The listed sponsor is Abbott Medical Optics, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hyperopia appearing as the primary indexed condition, and to 1 intervention - of which LASIK correction of hyperopic refractive errors is the first listed.
NCT01675479 reports 9 study locations spanning 8 distinct geographic areas - top geographies include Missouri, California, Florida.
Frequently Asked Questions
What is clinical trial NCT01675479 about?
NCT01675479 is a clinical study titled "Safety and Effectiveness of Wavefront-Guided LASIK Correction of Hyperopic Refractive Errors". Demonstrate that wavefront-guided LASIK using measurements from the iDesign System is safe and effective for the treatment of Hyperopia.
What is the current status of trial NCT01675479?
This trial is currently completed. It is a NA study. The enrollment target is 167 participants. The study started on 2012-12-31. Estimated completion is 2016-10-31.
What conditions does trial NCT01675479 study?
This clinical trial studies the following conditions: Hyperopia.
What interventions are being tested in trial NCT01675479?
The interventions under investigation include: LASIK correction of hyperopic refractive errors (DEVICE).
Who is sponsoring clinical trial NCT01675479?
This trial is sponsored by Abbott Medical Optics, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01675479 being conducted?
This trial has 9 study locations across California, Florida, Illinois, Missouri, New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hyperopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Comprehensive Assessment of Multiple Products (CAMP)
RECRUITING · NA
-
A Clinical Comparison of Proclear® 1 Day Multifocal and Clariti® 1 Day Multifocal 3 Add
RECRUITING · NA
-
Safety and Effectiveness of the TENEO 317 Model 2 (1.28 US) Excimer Laser for Laser In Situ Keratomileusis (LASIK) Surgery to Treat Hyperopia With or Without Astigmatism
ACTIVE NOT RECRUITING · NA
-
Hyperopia Treatment Study 1 (HTS1) - Glasses vs Observation
COMPLETED · NA
-
Clinical Investigation of the WaveLight® EX500 Excimer Laser
COMPLETED · NA
-
A Study to Evaluate the Safety and Effectiveness of the Technols 217z Zyoptix System for Hyperopia
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.